Cadila Healthcare submits press release

16 May 2020 Evaluate

Cadila Healthcare has informed that the Company enclosed a Press Release dated May 16, 2020 titled ‘Zydus Cadila receives tentative approval from USFDA for Droxidopa Capsules, 100 mg, 200 mg, and 300 mg’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

918.35 4.45 (0.49%)
17-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.10
Dr. Reddys Lab 1272.00
Cipla 1496.95
Zydus Lifesciences 918.35
Lupin 2113.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×